We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

158 hedge funds and large institutions have $309M invested in BioDelivery Sciences International, Inc. in 2020 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 59 increasing their positions, 40 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $485K | Put options by funds: $238K

48% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 40

37% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 19

18% more capital invested

Capital invested by funds: $263M → $309M (+$46.4M)

3% more funds holding

Funds holding: 153158 (+5)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
158
Holders Change
+5
Holders Change %
+3.27%
% of All Funds
3.24%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
59
Reduced
40
Closed
19
Calls
$485K
Puts
$238K
Net Calls
+$247K
Net Calls Change
+$865K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$34.2M +$3.08M +685,680 +10%
DM
2
Deerfield Management
New York
$28.5M +$1.62M +361,257 +6%
NCM
3
Nantahala Capital Management
Connecticut
$21.8M
Vanguard Group
4
Vanguard Group
Pennsylvania
$20.4M +$3.72M +826,762 +21%
RCMNY
5
Rubric Capital Management (New York)
New York
$17.4M +$978K +217,654 +6%
SFM
6
Systematic Financial Management
New Jersey
$12M +$1.65M +367,272 +15%
EA
7
Emerald Advisers
Pennsylvania
$9.18M +$26.3K +5,844 +0.3%
ACA
8
Avoro Capital Advisors
New York
$8.87M -$4.34M -965,100 -32%
State Street
9
State Street
Massachusetts
$8.79M +$466K +103,744 +5%
EMFAT
10
Emerald Mutual Fund Advisers Trust
Pennsylvania
$8.61M +$305K +67,766 +4%
Adage Capital Partners
11
Adage Capital Partners
Massachusetts
$8.5M
N
12
Nuveen
North Carolina
$7.93M +$479K +106,658 +6%
WA
13
Wasatch Advisors
Utah
$6.35M +$996K +221,564 +18%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$5.57M +$437K +97,328 +8%
PCM
15
Penn Capital Management
Pennsylvania
$5.38M +$426K +94,800 +8%
Two Sigma Advisers
16
Two Sigma Advisers
New York
$5.07M +$267K +59,300 +5%
Northern Trust
17
Northern Trust
Illinois
$4.85M +$436K +96,977 +10%
Goldman Sachs
18
Goldman Sachs
New York
$4.5M +$270K +60,087 +6%
SAM
19
Silvercrest Asset Management
New York
$4.26M -$76.3K -16,986 -2%
William Blair & Company
20
William Blair & Company
Illinois
$4.1M +$73.8K +16,428 +2%
Two Sigma Investments
21
Two Sigma Investments
New York
$3.58M -$788K -175,400 -18%
1CM
22
1492 Capital Management
Wisconsin
$3.49M -$59.1K -13,158 -2%
JAM
23
Jupiter Asset Management
United Kingdom
$3.12M +$3.21M +715,000 New
Renaissance Technologies
24
Renaissance Technologies
New York
$3.1M +$150K +33,463 +5%
Charles Schwab
25
Charles Schwab
California
$3M +$45.4K +10,102 +1%

BDSI Hedge Fund Activity: Q2 2020 in Review

158 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2020, worth a combined $309M — up 18% from $263M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new BDSI positions and 19 closed out — a net gain of 7 holders — while 59 added to existing stakes and 40 trimmed.

The largest buyer was Vanguard Group, adding an estimated $3.72M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $6.21M sold.

  • 158 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2020, up from 153 in Q1 2020.
  • Funds reported $309M of BioDelivery Sciences International, Inc. stock for Q2 2020, up 18% quarter-over-quarter.
  • 26 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2020 and 19 closed out, a net change of +7 holders.
  • The largest BioDelivery Sciences International, Inc. buyer in Q2 2020 was Vanguard Group, an estimated $3.72M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q2 2020 was Baker Bros. Advisors, an estimated $6.21M sold.

Based on aggregated 13F filings for Q2 2020.